Revere, MA, United States of America

Jian-cheng Wang

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Molecular Insight Pharmaceuticals, Inc.. Active years: 2013-2016.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 123(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Jian-cheng Wang

Introduction

Jian-cheng Wang is a notable inventor based in Revere, MA (US). He has made significant contributions to the field of imaging through his innovative patents. With a total of four patents to his name, Wang's work has advanced the methods used in medical imaging.

Latest Patents

Wang's latest patents include the development of technetium- and rhenium-bis(heteroaryl) complexes. These complexes are utilized in methods of imaging regions within a subject. The process involves administering a complex of a metal chelated to a compound, followed by obtaining an image of the targeted region in the subject. This innovative approach enhances the accuracy and effectiveness of imaging techniques.

Career Highlights

Wang is currently associated with Molecular Insight Pharmaceuticals, Inc., where he continues to push the boundaries of medical imaging technology. His work has been instrumental in developing new methods that improve diagnostic capabilities.

Collaborations

Wang has collaborated with esteemed colleagues such as John W Babich and Craig N Zimmerman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jian-cheng Wang's contributions to the field of imaging through his patents reflect his dedication to advancing medical technology. His work continues to impact the way imaging is performed, leading to better outcomes in patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…